Previous studies have demonstrated MLL-AF4 leukemias to have fewer additional mutations as compared to other leukemias, but have identified N-Ras, K-Ras, and Flt-3 as a source of potential cooperating mutations [36–40]. The gene discussed is KRAS; the disease is leukemia.